UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Boehringer Ingelheim Korea appoints Steven Walter as CEO
Steven Walter has begun serving as the head of the Korean branch of Boehrin...
by Marian Chu
|
2018-06-07 10:52
라인
Sanofi-Aventis Korea releases dyslipidemia therapy
Praluent Sanofi-Aventis Korea Tuesday launched dyslipidemia therapy Pralu...
by Marian Chu
|
2018-06-05 15:25
라인
Guerbet Korea accused of heavy-handed practices
Guerbet Korea has come under fire again for requesting 5-fold price hikes f...
by Marian Chu
|
2018-06-04 17:56
라인
Biggest life concern for Koreans is health, survey finds
A new survey shows that out of a variety of life stressors, a whopping 57 p...
by Marian Chu
|
2018-06-04 16:02
라인
Boston Scientific Korea launches deep brain stimulation system Vercise
Vercise system is comprised, from left, of electrode lines, remote controll...
by Marian Chu
|
2018-06-04 14:10
라인
SMC completes Korea’s 1st cryoballoon ablation
A medical team from Samsung Medical Center has completed the country’s firs...
by Marian Chu
|
2018-06-04 14:08
라인
Cigarette pack warning labels effective on teens: KCDC
The graphic warning labels slapped onto cigarette packages since 2016 are p...
by Marian Chu
|
2018-06-01 15:17
라인
Xarelto results in fewer strokes and systemic emboli for frail NVAF patients: study
A new study shows Xarelto (ingredient: rivaroxaban) to result in fewer stro...
by Marian Chu
|
2018-06-01 12:09
라인
Teva Handok gets reimbursement for narcolepsy drug
Teva Handok’s once-daily narcolepsy therapy Nuvigil (ingredient: armodafini...
by Marian Chu
|
2018-06-01 12:06
라인
YUHS, Celltrion to develop next-generation stroke therapy
Researchers from Yonsei University Health System (YUHS) will work with Cell...
by Marian Chu
|
2018-05-31 18:01
라인
Novartis Korea launches 2nd generation acromegaly therapy
Signifor LAR (pasireotide pamoate) Source: Korea Pharmaceutical Informati...
by Marian Chu
|
2018-05-31 17:48
라인
Leo Pharma Korea launches Enstilum foam for psoriasis
Enstilum foam Leo Pharma Korea has launched a spray-on, topical treatment...
by Marian Chu
|
2018-05-31 17:47
라인
‘Many Koreans still treat hives with steroids and 1st gen antihistamines’
Many Koreans are still taking first-generation antihistamines or steroids t...
by Marian Chu
|
2018-05-31 13:10
라인
AbbVie to challenge Gilead on hepatitis C front in Korea
AbbVie Korea’s winning of reimbursement for its hepatitis C treatment Mavyr...
by Marian Chu
|
2018-05-30 16:28
라인
Asian oncologists publish textbook on colorectal cancer
Sixty Asian oncologists have banded together to publish a textbook on the s...
by Marian Chu
|
2018-05-30 16:27
라인
Eli Lilly aims for migraine injection to touch down in Korea in 2019
New injections to prevent migraines with little or no side effects are now ...
by Marian Chu
|
2018-05-29 16:05
라인
Novo Nordisk Korea issues weight loss data of Saxenda
Novo Nordisk Korea published real-world study findings on its obesity treat...
by Marian Chu
|
2018-05-29 11:16
라인
Some drugs remain blockbusters even after patent expiration. Why?
What does hair loss treatment Propecia, cholesterol therapy Lipitor, and he...
by Marian Chu
|
2018-05-29 11:16
라인
Severance finds new treatment method for lupus nephritis
Professors Lee Sang-won (left) and Lee Sang-kyu Researchers at Severance ...
by Marian Chu
|
2018-05-28 16:58
라인
Novartis Korea gets additional indication for Revolade
Novartis Korea’s Revolade (ingredient: eltrombopag) can now be used to trea...
by Marian Chu
|
2018-05-28 12:00
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top